title: The effect of ring substituents on the mechanism of interaction of exogenous quinones with the mitochondrial respiratory chain.
abstract: In uncoupled pig-heart mitochondria the rate of the reduction of duroquinone by succinate in the presence of cyanide is inhibited by about 50% by antimycin. This inhibition approaches completion when myxothiazol is also added or British anti-Lewisite-treated (BAL-treated) mitochondria are used. If mitochondria are replaced by isolated succinate:cytochrome c oxidoreductase, the inhibition by antimycin alone is complete. The reduction of a plastoquinone homologue with an isoprenoid side chain (plastoquinone-2) is strongly inhibited by antimycin with either mitochondria or succinate:cytochrome c reductase. The reduction by succinate of plastoquinone analogues with an n-alkyl side chain in the presence of mitochondria is inhibited neither by antimycin nor by myxothiazol, but is sensitive to the combined use of these two inhibitors. On the other hand, the reduction of the ubiquinone homologues Q2, Q4, Q6 and Q10 and an analogue, 2,3-dimethoxyl-5-n-decyl-6-methyl-1,4-benzoquinone, is not sensitive to any inhibitor of QH2:cytochrome c reductase tested or their combined use, either in normal or BAL-treated mitochondria or in isolated succinate:cytochrome c reductase. It is concluded that quinones with a ubiquinone ring can be reduced directly by succinate:Q reductase, whereas those with a plastoquinone ring can not. Reduction of the latter compounds requires participation of either center i or center o (Mitchell, P. (1975) FEBS Lett. 56, 1-6) or both, of QH2:cytochrome c oxidoreductase. It is proposed that a saturated side chain promotes, while an isoprenoid side chain prevents reduction of these compounds at center o.
mesh_terms: D000818:Animals; D000968:Antimycin A / Q000031:analogs & derivatives / Q000494:pharmacology; D016227:Benzoquinones; D004112:Dimercaprol / Q000494:pharmacology; D004579:Electron Transport; D014450:Electron Transport Complex III / Q000378:metabolism; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction; D010971:Plastoquinone / Q000378:metabolism; D011809:Quinones / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013386:Succinates / Q000494:pharmacology; D019802:Succinic Acid; D013552:Swine; D014451:Ubiquinone / Q000378:metabolism
chemical_list: D016227:Benzoquinones; D011809:Quinones; D013386:Succinates; D004112:Dimercaprol; C032456:antimycin; D014451:Ubiquinone; D000968:Antimycin A; D019802:Succinic Acid; D014450:Electron Transport Complex III; D010971:Plastoquinone; C034257:duroquinone